Business Description
AegirBio AB
ISIN : SE0014401121
Share Class Description:
AEGBF: Ordinary SharesCompare
Compare
Traded in other countries / regions
AEGIR.Sweden52Q.GermanyAEGBF.USA IPO Date
2023-04-18Description
AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.68 | |||||
| Equity-to-Asset | 0.12 | |||||
| Debt-to-Equity | 4.59 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -17.87 | |||||
| Beneish M-Score | -10.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 151.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -36.09 | |||||
| 12-1 Month Momentum % | -36.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.53 | |||||
| Quick Ratio | 2.53 | |||||
| Cash Ratio | 2.12 | |||||
| Days Inventory | 364.26 | |||||
| Days Sales Outstanding | 16571 | |||||
| Days Payable | 72.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -42.8 | |||||
| Shareholder Yield % | -190.46 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -24398.99 | |||||
| Operating Margin % | -92450.51 | |||||
| Net Margin % | -372296.97 | |||||
| FCF Margin % | -51922.22 | |||||
| ROE % | -353.42 | |||||
| ROA % | -252.31 | |||||
| ROIC % | -75.44 | |||||
| ROC (Joel Greenblatt) % | -5905.88 | |||||
| ROCE % | -267.44 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 120.13 | |||||
| PB Ratio | 1.66 | |||||
| EV-to-EBIT | -0.07 | |||||
| EV-to-EBITDA | -0.07 | |||||
| EV-to-Revenue | 259.99 | |||||
| EV-to-FCF | -0.52 | |||||
| Earnings Yield (Greenblatt) % | -1428.57 | |||||
| FCF Yield % | -336.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:AEGBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AegirBio AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.009 | ||
| EPS (TTM) ($) | -1.795 | ||
| Beta | 0 | ||
| Volatility % | 36.09 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.11 | ||
| 12-1 Month Momentum % | -36.09 | ||
| 52-Week Range ($) | 0.11 - 0.17211 | ||
| Shares Outstanding (Mil) | 30.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AegirBio AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AegirBio AB Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
AegirBio AB Frequently Asked Questions
What is AegirBio AB(AEGBF)'s stock price today?
The current price of AEGBF is $0.11. The 52 week high of AEGBF is $0.17 and 52 week low is $0.11.
When is next earnings date of AegirBio AB(AEGBF)?
The next earnings date of AegirBio AB(AEGBF) is 2024-05-17.
Does AegirBio AB(AEGBF) pay dividends? If so, how much?
AegirBio AB(AEGBF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers